Clinical trials recruiting for Beta-Amyloid
3
Recruiting trials
9
US states with sites
5
Countries
67%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 2
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| Florida | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| North Carolina | 1 |
| Tennessee | 1 |
| Texas | 1 |
Top cities
Boston, Massachusetts 1Cordova, Tennessee 1Fairway, Kansas 1Indianapolis, Indiana 1Lady Lake, Florida 1Matthews, North Carolina 1Nashville, Tennessee 1Orlando, Florida 1Phoenix, Arizona 1San Antonio, Texas 1
Self-screener
Recruiting trials
- A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults
- Beta Amyloid PET/CT in Various Aβ-Related Disease
Related conditions
Trials recruiting for Beta-Amyloid often also study these conditions. Each links to its own recruiting-trial list.
Alzheimer's disease 617Prodromal Alzheimer's Disease 3Neurodegenerative Diseases 23Mild cognitive impairment 96Lewy Body Disease 13Frontotemporal Degeneration 5Dementia, Vascular 4Dementia 106Cognitive Dysfunction 32Cognitive Decline 31
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Beta-Amyloid trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.